✦ LIBER ✦

Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer

✍ Scribed by Jacqueline Duffour; Sophie Gourgou; Françoise Desseigne; Charles Debrigode; Laurent Mineur; Frédéric Pinguet; Sylvain Poujol; Patrick Chalbos; Françoise Bressole; Marc Ychou

Publisher: Springer
Year: 2006
Tongue: English
Weight: 289 KB
Volume: 60
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-006-0372-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Individual 5-FU dose adaptation in metas

Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen

✍ Marc Ychou; Jacqueline Duffour; Andrew Kramar; Charles Debrigode; Sophie Gourgou 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 236 KB

A randomized phase II study of two doses

A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer

✍ M. G. Fakih; A. Groman; J. McMahon; G. Wilding; J. R. Muindi 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 361 KB

Phase I/II study of irinotecan, 5-fluoro

Phase I/II study of irinotecan, 5-fluorouracil, andl-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer

✍ Ayumu Goto; Yasuhide Yamada; Ayumu Hosokawa; Takashi Ura; Tatsuhiro Arai; Tetsuy 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

Use of the folinic acid/5-fluorouracil/i

Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study

✍ Eric François; Jean-François Berdah; Emmanuel Chamorey; Gérard Lesbats; Eric Tei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 286 KB

A phase II study of irinotecan in combin

A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer

✍ Takeshi Kato; Hideyuki Mishima; Masakazu Ikenaga; Kouhei Murata; Hideyuki Ishida 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 259 KB

Biweekly oxaliplatin combined with oral

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study

✍ P. Comella; B. Massidda; S. Palmeri; A. Farris; L. De Lucia; D. Natale; L. Maior 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 190 KB